The VenaSeal™ closure system offers freedom from tumescent anesthesia, thermal nerve injury, and post-procedure compression stockings.1*
In the VeClose trial, VenaSeal system patients reported low intraprocedural pain scores on a 0-10 point scale.1
Subjects treated with the VenaSeal closure system had a quick return to work.2,3,4
Subjects treated with the VenaSeal system had less ecchymosis at day 3 than those treated with traditional RFA.1
Proportion of limbs free from varicose veins increased with time from 0% at baseline to 47% at six months.5
Some patients may benefit from the use of compression stockings post-procedure.
Results are from different clinical studies and do not represent a head-to-head comparison of the affected devices; results may differ in a head-to-head comparison. Chart is for illustration purposes only.
Morrison, N. VenaSeal Closure System vs. Radiofrequency Ablation for Incompetent Great Saphenous Veins (VeClose). 36-Month Results presented at: IVC; April 20,2017; Miami, FL.
Rasmussen, L.H., et al. Randomized Clinical Trial Comparing Endovenous Laser Ablation, Radiofrequency Ablation, Foam Sclerotherapy and Surgical Stripping for Great Saphenous Varicose Veins. Br J Surg. 2011; 98: 1079-1087.
Gibson, K., and Ferris, B. Cyanoacrylate Closure of Incompetent Great, Small and Accessory Saphenous Veins Without the Use of Post-procedure Compression: Initial Outcomes of a Post-market Evaluation of the VenaSeal System (WAVES Study).Vascular; 2016:Epub May 20, 2016; 1708538116651014.
Gibson K. Cyanoacrylate Closure of Incompetent Great, Small and Accessory Saphenous Veins without the use of Post-Procedure Compression: A Post-Market Evaluation of the VenaSeal System (WAVES trial): Twleve Month Data. Results presented at: Charing Cross; 2017; London, UK.
Almeida, J.l., Javier, J.J., Mackay, E.G., Bautista, C., Cher, D.J., Proebstle, T.M.. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg: Venous and Lymphatic Disorders. 2017.